Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$161.19 - $257.96 $1.67 Million - $2.66 Million
-10,331 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$247.59 - $304.47 $2.39 Million - $2.94 Million
-9,669 Reduced 48.35%
10,331 $2.74 Million
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $3.65 Million - $6.08 Million
-18,740 Reduced 48.37%
20,000 $5.78 Million
Q2 2021

Aug 13, 2021

BUY
$165.87 - $220.95 $6.43 Million - $8.56 Million
38,740 New
38,740 $7.73 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.